Comparison of Acoustic Variability Index (AVI) and Pulse Pressure Variation (PPV) for Predicting Fluid Responsiveness in Mechanically Ventilated Patients
A Prospective, Single-Center, Single-Arm, Paired-Comparison, Open-Label, Non-Inferiority Confirmatory Trial to Evaluate the Efficacy and Safety of ResQ by Comparing Fluid Responsiveness Prediction Performance of the Acoustic Variability Index (AVI) Versus Pulse Pressure Variation (PPV) in Mechanically Ventilated Patients
1 other identifier
observational
122
1 country
1
Brief Summary
The goal of this clinical trial is to learn if a new medical device called ResQ works to predict fluid needs in adults undergoing surgery under general anesthesia. The main questions it aims to answer are:
- Can the Acoustic Variability Index (AVI) measured by ResQ predict if a participant needs more fluids as accurately as the standard arterial blood pressure-based method (PPV)?
- Is the ResQ device safe to use during surgery? Researchers will compare the new method (AVI) to the standard method (PPV) to see if ResQ provides reliable information for managing patient fluids. Participants will:
- Undergo their planned surgery as scheduled.
- Have a soft probe placed in the esophagus to monitor heart and lung sounds.
- Receive a set amount of intravenous (IV) fluid as part of their regular surgery care.
- Have their heart function checked before and after the fluids are given.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 24, 2026
CompletedFirst Posted
Study publicly available on registry
April 8, 2026
CompletedStudy Start
First participant enrolled
April 13, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 9, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
July 14, 2026
CompletedJuly 17, 2026
July 1, 2026
3 months
March 24, 2026
July 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Comparison of Area Under the Receiver Operating Characteristic (ROC) Curve (AUC) between AVI and PPV for Predicting Fluid Responsiveness (Non-inferiority)
Assessed by calculating and comparing the Area Under the Curve (AUC) of the Receiver Operating Characteristic (ROC) curve for both indices to predict fluid responsiveness. The non-inferiority of AVI compared to PPV will be evaluated. Fluid responsiveness is defined as a Cardiac Output (CO) increase of 10% or more following a 500 mL fluid challenge.
Baseline (assessed continuously for 3 minutes before fluid challenge) and 3 minutes after a 500 mL fluid challenge
Secondary Outcomes (4)
Concordance of Respiratory Rate (RR) between ResQ and Carestation 750
Baseline (assessed continuously for 3 minutes before fluid challenge) and 3 minutes after a 500 mL fluid challenge.
Comparison of Area Under the Receiver Operating Characteristic (ROC) Curve (AUC) between AVI and PVI for Predicting Fluid Responsiveness
Baseline (assessed continuously for 3 minutes before fluid challenge) and 3 minutes after a 500 mL fluid challenge.
Comparison of Area Under the Receiver Operating Characteristic (ROC) Curve (AUC) between AVI and SVV for Predicting Fluid Responsiveness
Baseline (assessed continuously for 3 minutes before fluid challenge) and 3 minutes after a 500 mL fluid challenge
Diagnostic performance of AVI for fluid responsiveness (Sensitivity, Specificity, Positive Predictive Value, Negative Predictive Value)
Baseline (assessed continuously for 3 minutes before fluid challenge) and 3 minutes after a 500 mL fluid challenge
Study Arms (1)
Mechanically Ventilated Surgical Patients (Paired-Comparison)
Adult patients (aged 19 years or older) scheduled for elective major abdominal, retroperitoneal, or pelvic surgery under general anesthesia and mechanical ventilation. In this single-arm, within-subject paired-comparison cohort, each participant undergoes real-time monitoring of hemodynamic indices-specifically the Acoustic Variability Index (AVI) and Pulse Pressure Variation (PPV)-both before and after a standardized 500 mL fluid challenge. This design allows for a direct comparison of the two indices within the same physiological state for each participant.
Interventions
A standard multi-parameter patient monitor used to measure the reference hemodynamic index, Pulse Pressure Variation (PPV), via an arterial catheter
A patient monitoring system used to measure the Pleth Variability Index (PVI) via a non-invasive sensor attached to the finger or toe
An anesthesia delivery and monitoring system used to provide the reference Respiratory Rate (RR) measurement based on end-tidal CO2 (EtCO2) waveforms during general anesthesia
A biosignal processing device that measures AVI and RR continuously in real-time. It analyzes heart and lung sounds collected via a general-purpose internal probe inserted into the patient's esophagus.
A specialized hemodynamic monitoring system used to measure the reference standard for fluid responsiveness: Cardiac Output (CO) and Stroke Volume Variation (SVV)
Eligibility Criteria
The study population consists of adult patients at Asan Medical Center in Seoul, South Korea. Participants will be recruited from the patients scheduled to undergo elective major surgeries involving organs in the abdominal, retroperitoneal, or pelvic cavities (such as hepatobiliary, pancreatic, intestinal, renal, or uterine procedures). These patients will be receiving general anesthesia and mechanical ventilation and are expected to require continuous intraoperative hemodynamic monitoring as part of their standard surgical care.
You may qualify if:
- To participate in this study, individuals must meet all of the following criteria:
- Adults aged 19 years or older.
- If female, not pregnant or breastfeeding.
- Scheduled for a planned surgery of major organs in the abdominal, retroperitoneal, or pelvic cavities (e.g., hepatobiliary and pancreatic, small intestine, large intestine, kidney, uterus) under general anesthesia with mechanical ventilation
You may not qualify if:
- Scheduled to receive mechanical ventilation in a volume-controlled or pressure-controlled mode in the operating room or intensive care unit, with an anticipated tidal volume of 6-8 mL/kg (Ideal Body Weight), respiratory rate of 8-14 breaths/min, and PEEP of 0-5 cmH2O
- Scheduled for hemodynamic monitoring to measure the comparison indices during surgery
- Able to understand the study's purpose and procedures and communicate clearly with the investigator and research staff
- Voluntarily signed the written informed consent form before participating in the study
- Individuals meeting any of the following criteria will be excluded from participation:
- Undergoing emergency or unplanned surgery
- Anticipated to have difficulty with the application of general anesthesia or mechanical ventilation
- Anticipated to experience massive bleeding of 1 L or more during surgery.
- Undergoing a reoperation due to the same underlying disease
- History of severe esophageal damage (e.g., esophageal varices or stricture) that makes inserting the probe difficult
- Inability to have an arterial catheter inserted, making the measurement of Stroke Volume Variation (SVV) and Pulse Pressure Variation (PPV) difficult
- Condition where a fluid challenge is contraindicated or considered high risk (e.g., clinical signs of fluid overload, pulmonary congestion, or pulmonary edema; acute exacerbation of heart failure or renal failure; or a hemodynamically unstable state)
- Body Mass Index (BMI) greater than 30 kg/m²
- Uncontrolled coagulopathy prior to surgery (e.g., Platelet count \< 100,000/μL or INR \> 2)
- Arrhythmias, such as atrial fibrillation/flutter or premature atrial/ventricular contractions (\>2 per 10 seconds), that make it difficult for the variability index to operate accurately
- +3 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Signal House Co., Ltd.lead
- Ministry of SMEs and Startups, Koreacollaborator
Study Sites (1)
Asan Medical Center
Seoul, Seoul, 05505, South Korea
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hye-Mee Kwon, MD, PhD
Asan Medical Center
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 24, 2026
First Posted
April 8, 2026
Study Start
April 13, 2026
Primary Completion
July 9, 2026
Study Completion
July 14, 2026
Last Updated
July 17, 2026
Record last verified: 2026-07